BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33142921)

  • 1. Single-Cell Analysis of Different Stages of Oral Cancer Carcinogenesis in a Mouse Model.
    Huang LY; Hsieh YP; Wang YY; Hwang DY; Jiang SS; Huang WT; Chiang WF; Liu KJ; Huang TT
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.
    Tang XH; Knudsen B; Bemis D; Tickoo S; Gudas LJ
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):301-13. PubMed ID: 14734483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral-specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis.
    Paparella ML; Abrigo M; Bal de Kier Joffe E; Raimondi AR
    J Oral Pathol Med; 2015 Nov; 44(10):801-9. PubMed ID: 25605610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-treating with arecoline and 4-nitroquinoline 1-oxide to establish a mouse model mimicking oral tumorigenesis.
    Chang NW; Pei RJ; Tseng HC; Yeh KT; Chan HC; Lee MR; Lin C; Hsieh WT; Kao MC; Tsai MH; Lin CF
    Chem Biol Interact; 2010 Jan; 183(1):231-7. PubMed ID: 19840781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in long-lived epithelial stem cells and their clonal progeny in pre-malignant lesions and in oral squamous cell carcinoma.
    Melis M; Zhang T; Scognamiglio T; Gudas LJ
    Carcinogenesis; 2020 Nov; 41(11):1553-1564. PubMed ID: 32115621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No difference in 4-nitroquinoline induced tumorigenesis between germ-free and colonized mice.
    Zhou YX; Fuentes-Creollo G; Ponce F; Langley SA; Jen KY; Celniker SE; Mao JH; Snijders AM
    Mol Carcinog; 2019 May; 58(5):627-632. PubMed ID: 30632250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prostaglandin E2 receptor subtype EP1-selective antagonist, ONO-8711, suppresses 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
    Makita H; Mutoh M; Maruyama T; Yonemoto K; Kobayashi A; Fujitsuka H; Toida M; Shibata T; Miyamoto S; Yasui Y; Suzuki R; Wakabayashi K; Tanaka T
    Carcinogenesis; 2007 Mar; 28(3):677-84. PubMed ID: 17052996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by citrus auraptene in rats.
    Tanaka T; Kawabata K; Kakumoto M; Matsunaga K; Mori H; Murakami A; Kuki W; Takahashi Y; Yonei H; Satoh K; Hara A; Maeda M; Ota T; Odashima S; Koshimizu K; Ohigashi H
    Carcinogenesis; 1998 Mar; 19(3):425-31. PubMed ID: 9525276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular features of tongue epithelium treated with the carcinogen 4-nitroquinoline-1-oxide and alcohol as a model for HNSCC.
    Osei-Sarfo K; Tang XH; Urvalek AM; Scognamiglio T; Gudas LJ
    Carcinogenesis; 2013 Nov; 34(11):2673-81. PubMed ID: 23784083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene.
    Tanaka T; Makita H; Ohnishi M; Hirose Y; Wang A; Mori H; Satoh K; Hara A; Ogawa H
    Cancer Res; 1994 Sep; 54(17):4653-9. PubMed ID: 8062259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary silymarin suppresses 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats.
    Yanaida Y; Kohno H; Yoshida K; Hirose Y; Yamada Y; Mori H; Tanaka T
    Carcinogenesis; 2002 May; 23(5):787-94. PubMed ID: 12016151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of 63 hub genes during lingual carcinogenesis in C57BL/6J mice.
    Liu H; Li J; Yang Y; Liu L; Yu L; Tu M; Yuan R; Yue W; Luo Q; Ruan Y; Dai X
    Sci Rep; 2018 Aug; 8(1):12626. PubMed ID: 30135512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Ethanol and 4-Nitroquinoline-1-Oxide Induced Epigenetic and Oxidative Stress Markers During Oral Cavity Carcinogenesis.
    Urvalek AM; Osei-Sarfo K; Tang XH; Zhang T; Scognamiglio T; Gudas LJ
    Alcohol Clin Exp Res; 2015 Aug; 39(8):1360-72. PubMed ID: 26207766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effects of a selective cyclooxygenase-2 inhibitor, etodolac, on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
    Yamamoto K; Kitayama W; Denda A; Morisaki A; Kuniyasu H; Inoue M; Kirita T
    Exp Toxicol Pathol; 2004 Dec; 56(3):145-51. PubMed ID: 15625783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of the natural products indole-3-carbinol and sinigrin during initiation and promotion phases of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
    Tanaka T; Kojima T; Morishita Y; Mori H
    Jpn J Cancer Res; 1992 Aug; 83(8):835-42. PubMed ID: 1399821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4NQO carcinogenesis: a mouse model of oral cavity squamous cell carcinoma.
    Hawkins BL; Heniford BW; Ackermann DM; Leonberger M; Martinez SA; Hendler FJ
    Head Neck; 1994; 16(5):424-32. PubMed ID: 7960739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic toxic effects during early phases of topical 4-NQO-induced oral carcinogenesis in rats.
    Barcessat AR; Huang I; Rabelo GD; Rosin FC; Ferreira LG; de Cerqueira Luz JG; Corrêa L
    J Oral Pathol Med; 2014 Nov; 43(10):770-7. PubMed ID: 24931357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Bcl-2, SOCS 1, 3 and Cdh 1, 2 are associated with the early neoplasic changes in modified 4-nitroquinoline 1-oxide-induced murine oral cancer model.
    Cabrera Ortega AA; Gonçalves Vde P; Guimarães MR; Rossa Junior C; Spolidorio LC
    J Oral Pathol Med; 2016 Sep; 45(8):573-80. PubMed ID: 26778638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 4-nitroquinoline-1-oxide-induced rat oral carcinogenesis by dietary exposure of a new retinoidal butenolide, KYN-54, during the initiation and post-initiation phases.
    Makita H; Tanaka T; Ohnishi M; Tamai Y; Torihara M; Yamahara J; Mori H; Satoh K; Hara A
    Carcinogenesis; 1995 Sep; 16(9):2171-6. PubMed ID: 7554071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrequent Ha-ras mutations and absence of Ki-ras, N-ras, and p53 mutations in 4-nitroquinoline 1-oxide-induced rat oral lesions.
    Suzui M; Yoshimi N; Tanaka T; Mori H
    Mol Carcinog; 1995 Dec; 14(4):294-8. PubMed ID: 8519419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.